Cytosorbents Medical Inc.
Princeton, NJ Doing business as Cytosorbents Part of Cytosorbents Corporation
- UEI
- LSF2KFUSY4K7
- CAGE
- 5E0N2
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Cytosorbents Corporation
Parent
V2Y7G7L3ADL3
- Cytosorbents Medical Inc. LSF2KFUSY4K7
-
Cytosorbents Corporation
Parent
V2Y7G7L3ADL3
- SAM.gov registration date
- Physical address
- 305 College Rd E, Princeton, NJ 08540, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel sorbent technology for the rapid treatment of acute joint injury and inflammation | Air Force Research Laboratory | $74,918 | |
| Novel oral sorbent therapy for the prevention and treatment of travelers diarrhea | Air Force Research Laboratory | $74,955 | |
| Novel extracorporeal therapy for the reversal of septic shock and restoring hemodynamic stability - rationale: sepsis… | National Institute of General Medical Sciences | $1,140,340 | |
| Award of cytosorbents DHA sbir PH III MED r & d contract for "integrating isoagglutinin reduction for a universal… | Defense Health Agency | $4,292,641 | |
| Demonstration of the safety and efficacy of a field-ready blood group antibody BGA adsorber in a porcine universal… | Defense Health Agency | $1,977,024 |
About Cytosorbents Medical Inc.
Cytosorbents Medical Inc., doing business as Cytosorbents, is a for-profit manufacturer that provides medical devices and technologies to federal agencies through contracts and grants. The company develops blood purification technologies to treat critical care conditions.
Through federal contracts, Cytosorbents has provided the Defense Health Agency, Department of the Army, and Department of the Air Force with medical research and prototype development services under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) programs. As a small business, several of its awards have been set aside for Cytosorbents as the prime contractor. Specific goods and services provided include an extracorporeal cytokine adsorber to treat septic shock, a potassium adsorber to treat hyperkalemia, and an adsorber to remove anti-A and anti-B antibodies from blood for transfusion. Cytosorbents has partnered with federal agencies to further develop these medical device technologies.
Through federal grants, Cytosorbents Medical has received research project funding from the National Institutes of Health and Department of the Army Medical Command to demonstrate the safety and efficacy of its blood purification devices. This includes a $1.1 million project from NIH to evaluate a combination cytokine and endotoxin adsorber therapy for treating septic shock in animal models. It also includes a $2 million project grant from the DoD to test its blood group antibody adsorber for enabling universal blood transfusions in a porcine model. For both awards, Cytosorbents is the prime grantee responsible for conducting the research to advance its medical technologies.
Quick answers
What is Cytosorbents Medical Inc.'s UEI?
Cytosorbents Medical Inc.'s Unique Entity ID (UEI) in SAM.gov is LSF2KFUSY4K7.
What is Cytosorbents Medical Inc.'s CAGE code?
Cytosorbents Medical Inc.'s CAGE code is 5E0N2.
What is Cytosorbents Medical Inc.'s primary NAICS code?
Cytosorbents Medical Inc.'s primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).
Where is Cytosorbents Medical Inc. located?
Cytosorbents Medical Inc.'s physical address in SAM.gov is 305 College Rd E, Princeton, NJ 08540, USA.
Is Cytosorbents Medical Inc. registered in SAM.gov?
Yes. Cytosorbents Medical Inc.'s SAM.gov registration is active through December 12, 2026.
Who is Cytosorbents Medical Inc.'s parent company?
Cytosorbents Medical Inc. is part of Cytosorbents Corporation.
What is Cytosorbents Medical Inc.'s most recent federal award?
Cytosorbents Medical Inc.'s most recent federal contract award is Novel sorbent technology for the rapid treatment of acute joint injury and inflammation (FA864923P0777), from Air Force Research Laboratory, on May 12, 2023.
On GovTribe
See Cytosorbents Medical Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors